# ⬡ ChemoFilter: Protein-Protein Interaction (PPI) Node Mapping

**Predicting the Multi-Target "Interactome" Impact of a Lead**  
*The Systems Biology Logic for Tier 11 (Future Roadmap)*

---

## 1. Executive Overview

Most modern drug targets are no longer single enzymes (like Kinases) but **Protein-Protein Interactions (PPIs)**. A single drug can disrupt a specific node in a cellular network, affecting multiple biological pathways simultaneously.

**ChemoFilter** uses structural fingerprints in **Tier 9 (Aether Engine)** to map leads to potential PPI "Nodes" in the **Human Interactome** web.

---

## 2. PPI vs. Single-Target Binding

*   **Single-Target:** Binding to an active pocket (e.g., ATP-pocket of a kinase).
*   **PPI Fragment:** Binding to a shallow, large-surface-area interface (e.g., p53/MDM2).

**Logic:** If a lead has a very high **Molecular Weight ($MW > 600$)** and complex topology but still passes the **"Crystalline Obsidian"** toxicity screening, it is automatically flagged as a **"Potential PPI Disruptor"**.

---

## 3. The 3-Step Node Mapping Process

Tier 11 (Phase 4 Roadmap) will execute:

1.  **SMILES Encoding:** Using GNNs to represent the lead as a graph.
2.  **String-DB Integration:** Fetching protein-protein interaction networks for the primary target.
3.  **Impact Score:** Calculating the "Downstream Perturbation" (The Ripple Effect) on the metabolic web.

---

## 4. Significance in Oncology (Cancer Research)

Most "Cancer Lead" molecules act by disrupting PPI nodes in growth-factor pathways (e.g., MAPK, PI3K/Akt).

*   **ChemoFilter Implementation:** Identification of **Hydrophobic Patches** in the 3D 
conformational minimized state (Tier 9) that are characteristic of PPI interfacial binders.

---

## 5. Visualizing PPI: The "Interactome Spider" Chart

The UI features a **"Target Web" (Interactome Spider)** where:

*   **Node Centrality:** Shows the "Cruciality" of the target in the human metabolism.
*   **Edge Weight:** Shows the strength of the predicted drug-target interaction.
*   **Value:** An instant visualization of whether the drug will cause broad "System-Wide" changes or the "Surgical Strike" needed for a specific disease.

---

## 6. How to Extend This Engine

Phase 5 (Future Roadmap) involves training a **Graph Diffusion Model** to suggest purely generative PPI disruptors for "Undruggable" targets like transcription factors.
